←Back to Expert Scholars
Translational Medicine / 转化医学Cancer RNA Therapeutics, siRNA
Phillip Sharp
PhD
🏢Massachusetts Institute of Technology🌐USA
Institute Professor
140
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Phillip Sharp shared the 1993 Nobel Prize in Physiology or Medicine for the discovery of RNA splicing. He co-founded Alnylam Pharmaceuticals and is a leading voice in the RNA therapeutics field. His work spans fundamental RNA biology and translational cancer RNA research.
Share:
🧪Research Fields 研究领域
RNA splicing
siRNA
non-coding RNA
cancer RNA biology
RNA therapeutics
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Phillip Sharp 的研究动态
Follow Phillip Sharp's research updates
留下邮箱，当我们发布与 Phillip Sharp（Massachusetts Institute of Technology）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment